Ireland
--:--IST
Latest
Clinical Trials in Spain / NCT06706583
Recruiting Not applicable

Clinical and Ecological Impact of a Primary Care Antimicrobial Stewardship Program Based on Telematic Educational Interviews (TELÉMACO Trial)

NCT06706583 · tracked via the Priya Life Science Spain tracker
Phase
Not applicable
Started
2024-12-01
Last updated
2024-11-26

Condition(s) studied

Community Acquired Infections

Investigational drug(s) / intervention(s)

Telematic educational interviews + standard trainingStandard training

Telematic educational interviews + standard training: Physicians attending at healthcare centers in the experimental arm will receive periodic telematic educational interviews in which an Infectious Diseases consultant will provide practical training on the appropriate use of antibiotics through the review of one of the physician´s randomly chosen antibiotic prescription, according to a structured brief interview. In addition to this, each of these centres will continue carrying out the already established activities of the Regional ASP (PIRASOA).

Standard training: Primary Care Health Centers assigned to the control group will receive standard educational activities designated by the current Regional ASP (PIRASOA).

Study summary

Brief Summary: Open-label, cluster randomized, multicenter clinical trial to evaluate the clinical and ecological impact of a Primary Care ASP based on telematic educational interviews.

Eligibility

Sex
ALL
Min age
—
Max age
—
Healthy volunteers
No
Inclusion criteria: a) Primary Care centres within the reference area of the University Hospital Virgen del Rocío. Exclusion criteria: 1. Emergency departments. 2. Odontology offices. 3. DDD per Health centre less than 5.78

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Hospital Universitario Virgen del Rocío Seville Spain Recruiting

More Fundación Pública Andaluza para la gestión de la Investigación en Sevilla trials in Spain

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06706583 on ClinicalTrials.gov ↗ ← All trials in Spain